Petros Pharmaceuticals, Inc.
PTPI- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001815903
No open-market purchases or sales by Petros Pharmaceuticals, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Petros Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 22 | 19 | −3 |
| Shares | 963.6K | 812.7K | −150.8K (−15.7%) |
| Value | $3.02M | $1.82M | −$1.19M (−39.5%) |
New holders (0)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
None.
Sold out (3)
Institutions that held Petros Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Acorn Financial Advisory Services Inc | 50,200 | $157.0K |
| Virtu Financial LLC | 14,364 | $45.0K |
| Bank of America Corp | 34 | $0 |